Cognitive Behavioral Therapy for Insulin Resistance and HIV

This trial aims to determine if treating depression can improve insulin resistance (how well the body uses insulin) in people with HIV who are already receiving HIV treatment. Participants will either engage in an online program called cognitive behavioral therapy (CBT) with nine weekly sessions or receive educational materials about depression. People with HIV who have been on stable treatment for at least six months and experience moderate to severe depression might be suitable candidates for this trial.

As an unphased trial, this study provides a unique opportunity to contribute to understanding the broader impacts of mental health treatment on physical health in people with HIV.

The trial does not require you to stop taking your current medications, including antidepressants. However, you cannot receive treatment for hepatitis C during the study, and certain medications like systemic glucocorticoids or investigational agents are not allowed at the start of the trial.

Research has shown that internet-based cognitive behavioral therapy (iCBT-D) is generally safe for participants. Past studies indicate that people have tolerated iCBT-D well, with no serious side effects reported. This therapy uses an online platform to help manage depression by teaching users how to change negative thinking patterns. While some mild side effects, such as temporary emotional discomfort, may occur as individuals work through their feelings, these are usually manageable. Overall, evidence suggests that iCBT-D is a safe option for treating depression.¹²³⁴⁵

Researchers are excited about Internet Cognitive Behavioral Therapy (iCBT-D) for insulin resistance and HIV because it offers a new, convenient way to address mental health challenges associated with these conditions. Unlike traditional face-to-face therapy, iCBT-D is delivered online, making it more accessible for individuals who may have difficulty attending in-person sessions. This method uses an engaging, multimedia format with videos and interactive exercises, allowing participants to learn and apply cognitive behavioral techniques at their own pace. Additionally, it includes therapist assistance to ensure personalized support, which can enhance the effectiveness of the therapy. This innovative approach has the potential to improve both mental and physical health outcomes for people living with HIV.

Studies have shown that cognitive behavioral therapy (CBT) can improve symptoms of depression and may also aid in managing insulin resistance. For individuals with diabetes, CBT has improved blood sugar levels and diabetes management. Some research suggests that treating depression with CBT can enhance blood sugar control and reduce insulin resistance. In this trial, participants will receive Internet Cognitive Behavioral Therapy (iCBT-D) to evaluate its effectiveness. Online CBT, similar to the program under study, has proven effective when combined with lifestyle education to improve blood sugar levels. These findings support the idea that treating depression with CBT could help people with HIV manage insulin resistance more effectively.²⁴⁶⁷⁸